ALLMedicine™ Actinic Keratosis Center
Research & Reviews 912 results
Archives of Dermatological Research; Worley B, Harikumar V et. al.
Dec 2nd, 2022 - Treatment of actinic keratoses (AKs) can help lower the risk of eventual skin cancer and address field pre-cancerization. This review compares the different therapeutic options for actinic keratosis. Databases used include Medline, EMBASE, Web of ...
The American Journal of the Medical Sciences; Jung J, Waller JL et. al.
Nov 21st, 2022 - In the general population, cutaneous squamous cell carcinoma (cSCC) is associated with increased all-cause mortality. Transplant patients have been shown to have an increased risk of developing cSCC, and their cSCC is associated with an increased ...
Cancer Medicine; Huuskonen ML, Koistinen T et. al.
Nov 19th, 2022 - Little controlled evidence exists on road traffic accident (RTA) risk among patients diagnosed with cancer, while clinicians are often requested to comment their ability to drive. The aim of this study was to evaluate RTA risk in a population-base...
Journal of Cutaneous Pathology; Shahriari N, Grant-Kels JM et. al.
Nov 3rd, 2022 - Facial skin is characterized by high density of follicles. Facial neoplasms may present overlapping clinical and dermoscopic findings. Our goal was to evaluate and compare, via reflectance confocal microscopy (RCM), follicular involvement in facia...
Dermatology Online Journal; Safadi MG, Hassan S et. al.
Oct 20th, 2022 - Imiquimod is a topical immunomodulator that acts as an inducer of interferon (IFN)-a expression through Toll-like receptor (TLR)7 signaling with indications for the treatment of non-hyperkeratotic actinic keratosis of the face or scalp, superficia...
Guidelines 4 results
Journal of the European Academy of Dermatology and Venere... Richard MA, Amici JM et. al.
Dec 14th, 2017 - Actinic keratoses (AK) arise on sun-exposed regions of the skin. If left untreated, AK may progress to invasive squamous cell carcinoma (SCC), although the rate of progression is low. A practical treatment algorithm for the treatment of AK in stan...
The British Journal of Dermatology; de Berker D, McGregor JM et. al.
Jan 18th, 2017 - British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.|2017|de Berker D,McGregor JM,Mohd Mustapa MF,Exton LS,Hughes BR,|methods,methods,therapeutic use,therapeutic use,diagnosis,prevention & control...
Journal of the European Academy of Dermatology and Venere... Werner RN, Stockfleth E et. al.
Sep 16th, 2015 - Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing. The goal of these evidence- and consensus-based gui...
Journal of the European Academy of Dermatology and Venere... Dréno B, Amici JM et. al.
Mar 13th, 2014 - Actinic keratoses (AK) are common photo-induced cutaneous lesions that may progress to invasive squamous-cell carcinoma and serve as a risk marker for skin cancer. Although numerous studies present the various therapeutic options for AK, publicati...
Drugs 9 results see all →
Clinicaltrials.gov 193 results
Oct 10th, 2022 - Squamous cell carcinoma (SCC) of the lower extremity is a distinct subset of cutaneous squamous cell carcinomas which tend to occur multiply in elderly women. In contrast, the majority of cutaneous SCCs occur on the head and neck, and in men more ...
Sep 27th, 2022 - The aim of the study is to evaluate the safety and tolerability of PDT for treatment of mild to severe actinic keratosis on the face and scalp in the expanded treatment field using 3 tubes of BF-200 ALA 10% gel (Ameluz®) in conjunction with the BF...
Sep 19th, 2022 - Transient local skin reactions with topical Actinic Keratosis treatments such as 5-FluoroUracil (5-FU) often lead to non-adhesion from patients and thus to treatment failure. In regards to 5-FU treatment, these local reactions are related to the p...
Sep 14th, 2022 - Endeavoring to develop a new therapeutic and preventative strategy for patients with AK, this study aims to investigate the impact of 9-valent HPV vaccination on AK burden and -development over the course of 12 months. Seventy actinic keratosis (A...
Aug 23rd, 2022 - This Phase 2 clinical trial is a 3-part, open-label, multi-center study involving a non-occluded, daily topical dermal application of 1 of 2 strengths of VDA-1102 ointment for approximately 12 weeks (84 days) to an initial 2 cohorts of subjects. T...
News 189 results
Sep 9th, 2022 - MILAN – Application of topical or both topical and oral polypodium leucotomos extract (PLE) was associated with significant reversal of adverse skin changes in patients with severe actinic keratoses (AKs) treated over 12 months, in a randomized, b.
Sep 9th, 2022 - MILAN — Application of topical or both topical and oral polypodium leucotomos extract (PLE) was associated with significant reversal of adverse skin changes in patients with severe actinic keratoses (AKs) treated over 12 months, in a randomized, b...
MDedge Family Medicine;
Feb 17th, 2022 - Common skin reactions to treatment with topical 5-FU for actinic keratosis include erythema, ulceration, and burning. In this case, however, the skin disruption opened the door to secondary impetigo.
Dec 8th, 2021 - Pinker or redder actinic keratoses (AKs) indicate greater inflammation, according to a retrospective study that analyzed images and histopathology slides of 49 actinic keratosis lesions. Data suggest that up to 65% of squamous cell carcinomas (SCC.
Dec 4th, 2021 - The efficacy seen with ripretinib (Qinlock) in patients with KIT-mutated melanoma was higher than has been previously reported, according to Filip Janku, MD, PhD. Furthermore, the switch-control tyrosine kinase inhibitor (TKI) has elicited durable...